Aclaris Therapeutics, Inc. (ACRS)

Price$6.17Cached quote
ACRSNasdaq
Loading local price history

Financial charts

Revenue

Net income

Total cash / debt

CashTotal debt

Financial statements

13 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013
Revenue$7.8M$18.7M$31.2M$29.8M$6.8M$6.5M$4.2M$6.2M$1.7M————
Gross profit$5.7M$15.9M$27.8M$25.7M$2.0M$1.3M$172,000$3.2M$476,000————
Gross margin73.28%85.09%89.05%86.48%30.29%20.81%4.07%52.69%28.28%————
Research & development$52.6M$33.6M$98.4M$77.8M$43.8M$29.3M$64.2M$60.8M$35.8M$33.5M$15.3M$6.5M$3.5M
Operating expenses$84.2M$160.7M$128.6M$119.6M$96.5M$57.4M$115.3M$90.9M$56.0M$48.6M$20.7M$8.5M$5.3M
Operating income−$76.4M−$141.9M−$97.4M−$89.9M−$89.7M−$50.9M−$111.1M−$84.8M−$54.4M−$48.6M−$20.7M−$8.5M−$5.3M
Operating margin−975.91%−758.18%−311.55%−302.01%−1,327.07%−785.44%−2,627.35%−1,378.31%−3,230.01%————
EBITDA−$75.9M−$141.1M−$96.5M−$89.1M−$88.8M−$49.6M−$104.6M−$82.9M−$54.0M−$48.4M−$20.6M−$8.5M−$5.2M
EBITDA margin−970.11%−753.87%−308.79%−299.33%−1,313.42%−765.01%−2,475.73%−1,347.76%−3,206.12%————
Net income−$64.9M−$132.1M−$88.5M−$86.9M−$90.9M−$51.0M−$161.4M−$132.7M−$68.5M−$48.1M−$20.6M−$8.5M−$5.2M
Net profit margin−829.58%−705.48%−283.15%−292.11%−1,343.96%−787.03%−3,817.22%−2,157.99%−4,071.48%————
Basic EPSper basic share-$0.53-$1.71-$1.27-$1.33-$1.60-$1.20-$3.90-$4.03-$2.44-$2.25-$3.79-$6.15-$6.45
Diluted EPSper diluted share-$0.53-$1.71-$1.27-$1.33-$1.60-$1.20-$3.90-$4.03-$2.44-$2.25-$3.79-$6.15-$6.45

Owners

Reported shareholders

Reference date Jun 30, 2026
Leonard Braden Michael · ≈9.98% of listed sharesRA CAPITAL MANAGEMENT, L.P. · 9.10% of listed sharesBML Capital Management, LLC · 8.56% of listed sharesBlackRock, Inc. · 7.18% of listed sharesDeep Track Capital, LP · 6.68% of listed sharesVivo Capital, LLC · 4.79% of listed sharesVANGUARD CAPITAL MANAGEMENT LLC · 4.16% of listed sharesFrazier Life Sciences Management, L.P. · 3.52% of listed sharesRock Springs Capital Management LP · 3.10% of listed sharesADAGE CAPITAL PARTNERS GP, L.L.C. · 2.91% of listed sharesDecheng Capital LLC · 2.89% of listed sharesKalehua Capital Management LLC · 2.62% of listed sharesSTATE STREET CORP · 2.33% of listed sharesGEODE CAPITAL MANAGEMENT, LLC · 2.28% of listed sharesBRAIDWELL LP · 1.53% of listed sharesBalyasny Asset Management L.P. · 1.45% of listed sharesSILVERARC CAPITAL MANAGEMENT, LLC · 1.39% of listed sharesCITADEL ADVISORS LLC · 1.26% of listed sharesJones Hill Capital LP · 1.26% of listed sharesACADIAN ASSET MANAGEMENT LLC · 1.17% of listed shares
≈9.98%of listed shares
Leonard Braden Michael13.95M shares · Apr 27, 2026
View holders
Top 20 reported holders of ACRS
Holder% owned
Leonard Braden Michael
≈9.98%13.95M shares
RA CAPITAL MANAGEMENT, L.P.
9.10%12.72M shares
BML Capital Management, LLC
8.56%11.98M shares
BlackRock, Inc.
7.18%10.04M shares
Deep Track Capital, LP
6.68%9.35M shares
Vivo Capital, LLC
4.79%6.69M shares
VANGUARD CAPITAL MANAGEMENT LLC
4.16%5.82M shares
Frazier Life Sciences Management, L.P.
3.52%4.93M shares
Rock Springs Capital Management LP
3.10%4.33M shares
ADAGE CAPITAL PARTNERS GP, L.L.C.
2.91%4.07M shares
Decheng Capital LLC
2.89%4.04M shares
Kalehua Capital Management LLC
2.62%3.66M shares
STATE STREET CORP
2.33%3.26M shares
GEODE CAPITAL MANAGEMENT, LLC
2.28%3.19M shares
BRAIDWELL LP
1.53%2.14M shares
Balyasny Asset Management L.P.
1.45%2.02M shares
SILVERARC CAPITAL MANAGEMENT, LLC
1.39%1.95M shares
CITADEL ADVISORS LLC
1.26%1.76M shares
Jones Hill Capital LP
1.26%1.76M shares
ACADIAN ASSET MANAGEMENT LLC
1.17%1.64M shares

Percentages use 139.82M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.

Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.

Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys15$4.68M disclosed value
Sells (SEC code S)1$1.36M disclosed value
16 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Apr 23, 2026Form 4Leonard Braden MichaelTenPercentOwnerSellCommon Stock · indirect300.0K$4.53$1.36M13.95M
Nov 19, 2024Form 4Mehra AnandDirectorBuyCommon Stock666.7K$2.25$1.50M710.0K
Aug 5, 2024Form 4Leonard Braden MichaelTenPercentOwnerBuyCommon Stock · indirect206.0K$1.24$255.5K14.25M
Aug 2, 2024Form 4Leonard Braden MichaelTenPercentOwnerBuyCommon Stock · indirect167.5K$1.29$216.1K14.04M
Jul 31, 2024Form 4Leonard Braden MichaelTenPercentOwnerBuyCommon Stock · indirect100.0K$1.33$133.0K13.88M

Community posts

It’s quiet here.

No posts about ACRS yet. Start the conversation.

Write the first post